INVEST-DEVELOPMENT (MOEX:IDVP)

Sage Therapeutics Revenue

INVEST-DEVELOPMENT had revenue of 8.64M RUB in the half year ending June 30, 2024, with 26.97% growth. This brings the company's revenue in the last twelve months to 21.85M, down -25.77% year-over-year. In the year 2022, INVEST-DEVELOPMENT had annual revenue of 33.27M with 389.12% growth.

• Revenue (ttm): 21.85M
• Revenue Growth: -25.77%
• P/S Ratio: 1,159.26
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 25.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	33.27M	26.46M	389.12%
Dec 31, 2021	6.80M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-